Home › Funds › Point72 Asset Management › LXEO
Point72 Asset Management position in LXEO
LEXEO THERAPEUTICS INC · Health Care
Latest position (Q1 2026)1.68M sh
Reported value held$9.65M
Portfolio Weight0.01%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 370.41K | $3.35M | New |
| Q4 2024 | 750.24K | $4.94M | Add |
| Q1 2025 | 1.10M | $3.81M | Add |
| Q1 2025 | 1.10M | $3.81M | Add |
| Q2 2025 | 647.88K | $2.60M | Reduce |
| Q2 2025 | 647.88K | $2.60M | Reduce |
| Q3 2025 | 1.94M | $12.89M | Add |
| Q4 2025 | 1.89M | $18.81M | Reduce |
| Q1 2026 | 1.68M | $9.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LXEO
- Vanguard Group 3.89M sh · $38.67M · Q4 2025
- Janus Henderson Group 4.98M sh · $28.51M · Q1 2026
- BlackRock Inc 5.74M sh · $26.72M · Q2 2026
- Citadel Advisors 3.90M sh · $18.15M · Q2 2026
- Millennium Management 2.83M sh · $13.19M · Q2 2026
- Balyasny Asset Management 2.41M sh · $11.23M · Q2 2026
- Goldman Sachs Group 2.15M sh · $10.01M · Q2 2026
- Geode Capital Management 1.75M sh · $8.14M · Q2 2026
- Northern Trust Corp 867.39K sh · $4.04M · Q2 2026
- Bank of America Corp 490.33K sh · $2.28M · Q2 2026
- Morgan Stanley 395.10K sh · $1.84M · Q2 2026
- UBS Group AG 354.04K sh · $1.65M · Q2 2026